CURE logoCURE
Direxion Daily Healthcare Bull 3X Shares

1,703
Loading...
Loading...
News
all
press releases
News Placeholder
Eli Lilly Raises Full-Year Guidance By Whopping $3 Billion, Draws Retail Cheer
The major highlight of the pharmaceutical giant’s earnings came in the form of an increase in its full-year guidance by $3 billion to the range of $45.40 billion to $46.60 billion. The upgraded outlook was primarily driven by the strong performance of Mounjaro and Zepbound, as well as the firm’s non-incretin medicines.
Stocktwits·1y ago

Latest CURE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.